NVS – novartis ag (US:NASDAQ)
Stock Stats
News
1/12
09:52 am
nvs
Low
SciNeuro, Novartis sign $1.7 billion licensing deal to develop Alzheimer's drugs [Yahoo! Finance]
1/12
08:55 am
nvs
Low
SciNeuro and Novartis Enter into a Licensing and Collaboration Agreement for Next Generation Therapeutics to Treat Alzheimer's Disease [Yahoo! Finance]
1/12
08:27 am
nvs
Low
Gradalis Appoints Steven D. Weinstein as Chief Executive Officer [Yahoo! Finance]
1/9
01:10 pm
nvs
Low
Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investment [Yahoo! Finance]
1/9
10:30 am
nvs
Low
Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investment
10/28/2025
02:00 am
nvs
-1.7%
MISS
7/18/2025
04:05 pm
nvs
-0.1%
BEAT
7/17/2025
04:05 pm
nvs
-0.3%
BEAT
7/17/2025
06:20 am
nvs
-2.7%
BEAT
1/6
02:59 pm
Upgrades
Underweight
Equal-Weight
Barclays
Low
0.2%
1/6
02:59 pm
Upgrades
Underweight
Equal-Weight
Barclays
Low
0.2%
1/6
02:00 pm
Upgrades
Underweight
Equal Weight
Barclays PLC
Low
0.9%
12/10
07:21 am
Reiterates
Reduce
Reduce
HSBC Holdings plc
Low
0.3%
12/8
08:35 am
Upgrades
Neutral
Overweight
JPMorgan Chase & Co.
Low
-2.3%
11/25
06:01 am
nvs
Low
Form 6-K NOVARTIS AG For: Nov 24
11/20
06:05 am
nvs
Low
Form 6-K NOVARTIS AG For: Nov 20
11/5
04:33 pm
nvs
Low
Form 6-K NOVARTIS AG For: Nov 05
11/4
06:08 am
nvs
Low
Form FWP NOVARTIS AG Filed by: NOVARTIS AG
10/28
06:07 am
nvs
Low
Form 6-K NOVARTIS AG For: Sep 30
Show more
Top News Gainers
3/4 BRIEF-Novartis has stock to cover production, distribution for now, monitoring India API changes [Reuters] 4.8%
7/17 The Multibillion-Dollar Race for Gene Therapy Manufacturing Is On [The Motley Fool] 4.5%
5/23 Sosei Heptares Notes That a Valid Marketing Authorization Application For QVM149, a Potential New Inhaled Combination Therapy For Asthma, Has Been Filed With the European Medicines Agency 3.6%
8/11 5 Reasons Novartis Shareholders Aren't Shaken [The Motley Fool] 3.4%
8/7 Glancy Prongay & Murray LLP Announces Investigation on Behalf of Novartis AG Investors (NVS) 2.7%
4/4 Novartis AG (NYSE: NVS) had its "buy" rating re-affirmed by analysts at Goldman Sachs Group Inc. They now have a $116.00 price target on the stock. 2.7%
4/13 Novartis: Recent Selloff Has Presented A Buying Opportunity [Seeking Alpha] 2.4%
3/24 BRIEF-Novartis says Zolgensma helped SMA patients up to 5 years after dosing [Reuters] 2.2%
4/2 New York City hospital worker who caught coronavirus returns to treat patients [FOX News] 2.2%
3/10 INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Novartis AG and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm 1.9%
Top News Decliners
2/24 BRIEF-Novartis Announces FDA And EMA Filing Acceptance Of Ofatumumab [Reuters] -6.9%
4/28 Novartis sales, profits rise in first quarter on COVID-19 buying rush [Reuters (UK)] -3.2%
2/25 Novartis AG (NYSE: NVS) was downgraded by analysts at Guggenheim from a "buy" rating to a "neutral" rating. -3.0%
9/13 BRIEF-Novartis Says Neuronal And Glial Filaments Have Potential To Support Management Of MS Patient [Reuters] -2.8%
4/6 Special Report: Doctors embrace drug touted by Trump for COVID-19, without hard evidence it works [Reuters] -2.7%
3/3 BRIEF-Novartis Receives Health Canada Approval For Mayzent [Reuters] -2.7%
3/20 UPDATE 2-Novartis to donate malaria drug in fight against coronavirus [Reuters] -2.4%
7/11 BRIEF-Novartis, Amgen And Banner Alzheimer's Institute Discontinue Clinical Program With Bace Inhibitor CNP520 [Reuters] -2.3%
3/9 ROSEN, A LEADING LAW FIRM, Continues to Investigate Securities Claims Against Novartis AG – NVS -2.2%
3/20 Novartis to donate malaria drug in fight against coronavirus [Reuters] -2.2%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3